OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5
Unit: Days
Value type: Mean
Lower bound: 4
Upper bound: 6
Bounds: 4 - 6
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 94
Sample size: 249
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3
Unit: Days
Value type: Mean
Lower bound: 0
Upper bound: 42
Bounds: 0 - 42
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 94
Sample size: 249
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 12
Unit: Days
Value type: Mean
Lower bound: 0
Upper bound: 83
Bounds: 0 - 83
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 94
Sample size: 249
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 19
Unit: Days
Value type: Mean
Lower bound: 2
Upper bound: 92
Bounds: 2 - 92
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 94
Sample size: 249
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 7.56
Unit: Percentage (%)
Lower bound: 7.62
Upper bound: 7.32
Bounds: 7.62 - 7.32
CFR/IFR numerator: 185
CFR/IFR denominator: 2445
CFR/IFR method: Adjusted
Disaggregated by: Region
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 1
Maximum age: 93
Sample size: 2445
Country: China
Location: Beijing
Study period: 1 Mar 03 2003 to 16 Aug 08 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 21.993
Lower bound: 10.612
Upper bound: 29.058
Bounds: 10.612 - 29.058
Disaggregated by: Region
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 93
Country: China
Location: Beijing
Study period: 1 Mar 03 2003 to 16 Aug 08 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 93
Country: China
Location: Beijing
Study period: 1 Mar 03 2003 to 16 Aug 08 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 7.28
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 120
CFR/IFR denominator: 1649
CFR/IFR method: Naive
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 93
Sample size: 1649
Country: China
Location: Beijing
Study period:   2003 to 7 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Cormobidity;Hospitalisation;Occupation;Other
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 93
Sample size: 1649
Country: China
Location: Beijing
Study period:   2003 to 7 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 93
Sample size: 1649
Country: China
Location: Beijing
Study period:   2003 to 7 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Hospitalisation;Occupation;Other
Risk factor outcome: Death
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 93
Sample size: 1649
Country: China
Location: Beijing
Study period:   2003 to 7 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 80
Unit: Percentage (%)
Value type: Mean
CFR/IFR numerator: 12
CFR/IFR denominator: 15
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 15
Country: Taiwan,  China
Location: Kaohsiung
Study period: 26 Apr 04 2003 to 26 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 0
Unit: Percentage (%)
Value type: Mean
CFR/IFR numerator: 0
CFR/IFR denominator: 115
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 115
Country: Taiwan,  China
Location: Kaohsiung
Study period: 26 Apr 04 2003 to 26 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - serial interval
Parameter value: 8.4
Unit: Days
Value type: Mean
Uncertainty single value: 3.8 (Standard Deviation)
Combined uncertainty: 3.8 (Standard Deviation)
Distribution type: Weibull
Epidemic phase: Mid outbreak
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Sample size: 205
Country: Singapore
Study period: 25 Feb 02 2003 to 5 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - serial interval
Parameter value: 10
Unit: Days
Value type: Mean
Uncertainty single value: 2.8 (Standard Deviation)
Combined uncertainty: 2.8 (Standard Deviation)
Epidemic phase: Start outbreak
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Singapore
Study period: 25 Feb 02 2003 to  Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Unit: No units
Lower bound: 2.2
Upper bound: 3.6
Bounds: 2.2 - 3.6
Epidemic phase: Mid outbreak
Reproduction number method: Growth rate
Reproduction number pathway: Human-human
Disaggregated by: Other, Time
Population group: Persons under investigation
Sample type: Mixed settings
Sample size: 425
Study period: 15 Feb 02 2003 to 28 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 3.5
Unit: No units
Value type: Mean
Lower bound: 1.1
Upper bound: 7.7
Bounds: 1.1 - 7.7
Uncertainty type: 90% CrI
Uncertainty lower value: 1.5
Uncertainty upper value: 7.7
Combined uncertainty: 1.5 - 7.7 (90% CrI)
Reproduction number method: Growth rate
Reproduction number pathway: Human-human
Disaggregated by: Time
Sample size: 425
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Housing estate based
Sex: Unspecified
Country: Hong Kong SAR,  China
Location: Amoy Gardens
Study period: 11 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: End outbreak
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Community based
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period: 11 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.8
Unit: Days
Value type: Median
Uncertainty single value: 3.8 (Other)
Combined uncertainty: 3.8 (Other)
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 46
Country: Taiwan,  China
Location: Mackay Memorial Hospital
Study period: 18 Apr 04 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 8
CFR/IFR denominator: 46
CFR/IFR method: Naive
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 46
Country: Taiwan,  China
Location: Mackay Memorial Hospital
Study period: 18 Apr 04 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 46
Country: Taiwan,  China
Location: Mackay Memorial Hospital
Study period: 18 Apr 04 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 46
Country: Taiwan,  China
Location: Mackay Memorial Hospital
Study period: 18 Apr 04 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 46
Country: Taiwan,  China
Location: Mackay Memorial Hospital
Study period: 18 Apr 04 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 46
Country: Taiwan,  China
Location: Mackay Memorial Hospital
Study period: 18 Apr 04 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 2.65
Unit: No units
Value type: Other
Uncertainty type: 90% CI
Uncertainty lower value: 0.57
Uncertainty upper value: 12.45
Combined uncertainty: 0.57 - 12.45 (90% CI)
Population group: Persons under investigation
Sample type: Hospital based
Country: Taiwan,  China
Location: Taipei Municipal Ho-Ping Hospital, National Taiwan University Hospital
Study period: 29 Apr 04 2003 to 8 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 90
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR denominator: 390
Epidemic phase: End outbreak
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Sample size: 390
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 8.7
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 61.5
Bounds: 0 - 61.5
CFR/IFR numerator: 41
CFR/IFR denominator: 473
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Disaggregated by: Age, Method
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Minimum age: 10
Maximum age: 88
Sample size: 473
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 28.3
Value type: Unspecified
Lower bound: 7.2
Upper bound: 51.5
Bounds: 7.2 - 51.5
Epidemic phase: Unspecified
Disaggregated by: Region
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 632683
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 4.5
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 2
Upper bound: 7.3
Bounds: 2 - 7.3
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Healthcare workers
Sample type: Contact based
Sex: Unspecified
Sample size: 402
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 7.4
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 23.3
Bounds: 0 - 23.3
Epidemic phase: Unspecified
Disaggregated by: Region
Population group: Persons under investigation
Sample type: Contact based
Sex: Unspecified
Sample size: 474
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4.3
Unit: Days
Value type: Mean
Uncertainty single value: 1.6 (Standard Deviation)
Combined uncertainty: 1.6 (Standard Deviation)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 2.1
Unit: Days
Value type: Mean
Uncertainty single value: 3.2 (Standard Deviation)
Combined uncertainty: 3.2 (Standard Deviation)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Notification
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 9.4
Unit: Days
Value type: Mean
Lower bound: 4.3
Upper bound: 19
Bounds: 4.3 - 19
Epidemic phase: Unspecified
Disaggregated by: Age
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 41
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 12.8
Unit: Days
Value type: Mean
Uncertainty type: Range
Uncertainty lower value: 4
Uncertainty upper value: 31
Combined uncertainty: 4 - 31 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 23
Country: China
Location: Dongcheng District, Beijing
Study period: 14 Mar 03 2003 to 22 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Sex
Risk factor outcome: Attack Rate
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Population based
Sex: Both
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 20 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 7.8
Unit: Days
Value type: Mean
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 595
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 20 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 6.4
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0.5
Upper bound: 27.7
Bounds: 0.5 - 27.7
CFR/IFR numerator: 156
CFR/IFR denominator: 2444
CFR/IFR method: Unspecified
Epidemic phase: Mid outbreak
Disaggregated by: Age
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 2444
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 20 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 8.4
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 190
CFR/IFR method: Adjusted
Epidemic phase: Post outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 20 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 2444
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 20 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Unit: Percentage (%)
Lower bound: 55
Upper bound: 98
Bounds: 55 - 98
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Sample size: 164
Country: China
Location: Beijing
Study period: 5 Mar 03 2003 to 20 May 05 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 18.6
Value type: Unspecified
Lower bound: 2.5
Upper bound: 32.6
Bounds: 2.5 - 32.6
Epidemic phase: Unspecified
Disaggregated by: Age, Sex
Population group: General population
Sample type: Population based
Sex: Both
Country: China
Location: Beijing
Study period: 8 Mar 03 2003 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Sex
Risk factor outcome: Attack Rate
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Population based
Sex: Both
Country: China
Location: Beijing
Study period: 8 Mar 03 2003 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Incidence
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period: 8 Mar 03 2003 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4.1
Unit: Days
Value type: Mean
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 1876
Country: China
Location: Beijing
Study period: 8 Mar 03 2003 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 7.6
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 1.4
Upper bound: 24.5
Bounds: 1.4 - 24.5
CFR/IFR numerator: 192
CFR/IFR denominator: 2521
CFR/IFR method: Unspecified
Epidemic phase: Unspecified
Disaggregated by: Occupation, Region, Time
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 93
Sample size: 2521
Country: China
Location: Beijing
Study period: 8 Mar 03 2003 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age
Risk factor outcome: Mortality
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Population based
Sex: Both
Country: China
Location: Beijing
Study period: 8 Mar 03 2003 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Sex
Risk factor outcome: Mortality
Risk factor significance: Not significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Population based
Sex: Both
Country: China
Location: Beijing
Study period: 8 Mar 03 2003 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.83
Unit: Days
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 4.37
Uncertainty upper value: 5.29
Uncertainty single value: 0.235 (Standard Error)
Combined uncertainty: 4.37 - 5.29 (95% CI)
Distribution type: Weibull
Distribution parameter 1: 5.44 (Scale)
Distribution parameter 2: 1.91 (Shape)
Population group: Persons under investigation
Sample type: Mixed settings
Sex: Unspecified
Sample size: 198
Country: Singapore
Study period:  Mar 03 2003 to  Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Overdispersion
Parameter type: Overdispersion
Parameter value: 1.1882
Value type: Mean
Lower bound: 0.84123
Upper bound: 6.1781
Bounds: 0.84123 - 6.1781
Uncertainty single value: 0.575 (Standard Deviation)
Combined uncertainty: 0.575 (Standard Deviation)
Epidemic phase: Start outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Hospital based
Sample size: 2048
Country: China
Location: Beijing
Study period: 7 Mar 03 2003 to 20 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Overdispersion
Parameter type: Overdispersion
Parameter value: 2.6311
Value type: Mean
Lower bound: 0.1013
Upper bound: 115.85
Bounds: 0.1013 - 115.85
Uncertainty single value: 14.077 (Standard Deviation)
Combined uncertainty: 14.077 (Standard Deviation)
Epidemic phase: End outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Hospital based
Sample size: 2048
Country: China
Location: Beijing
Study period: 20 Apr 04 2003 to 4 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: beta - per capita contact rate per unit of time
Parameter value: 0.5459
Unit: Per day
Value type: Mean
Lower bound: 0.3525
Upper bound: 0.6109
Bounds: 0.3525 - 0.6109
Uncertainty single value: 0.0335 (Standard Deviation)
Combined uncertainty: 0.0335 (Standard Deviation)
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Hospital based
Sample size: 2048
Country: China
Location: Beijing
Study period: 7 Mar 03 2003 to 4 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - latent period
Parameter value: 6.868132
Unit: Days
Value type: Mean
Lower bound: 4.694836
Upper bound: 6.997901
Bounds: 4.694836 - 6.997901
Uncertainty type: Range
Uncertainty lower value: 4.694836
Uncertainty upper value: 6.997901
Combined uncertainty: 4.694836 - 6.997901 (Range)
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Hospital based
Sample size: 2048
Country: China
Location: Beijing
Study period: 7 Mar 03 2003 to 4 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - infectious period
Parameter value: 0.2064
Unit: Days
Value type: Mean
Lower bound: 0.1429
Upper bound: 0.2366
Bounds: 0.1429 - 0.2366
Uncertainty single value: 0.0118 (Standard Deviation)
Combined uncertainty: 0.0118 (Standard Deviation)
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Hospital based
Sample size: 2048
Country: China
Location: Beijing
Study period: 7 Mar 03 2003 to 4 Jun 06 2003